A semicrystalline
p-type thermoelectric conjugated polymer based
on a polymer backbone of cyclopentadithiophene and benzothiadiazole,
poly[(4,4′-(bis(hexyldecylsulfanyl)methylene)cyclopenta[2,1-b:3,4-b′]dithiophene)-alt-(benzo[c][1,2,5]thiadiazole)] (PCPDTSBT), is designed
and synthesized by replacing normal alkyl side-chains with bis(alkylsulfanyl)methylene
substituents. The sp2-hybridized olefinic bis(alkylsulfanyl)methylene
side-chains and the sulfur–sulfur (S–S) chalcogen interactions
extend a chain planarity with strong interchain packing, which is
confirmed by density functional calculations and morphological studies,
i.e., grazing incidence X-ray scattering measurement. The doping,
electrical, morphological, and thermoelectric characteristics of PCPDTSBT
are investigated by comparison with those of poly[(4,4′-bis(2-ethylhexyl)cyclopenta[2,1-b:3,4-b′]dithiophene)-alt-(benzo[c][1,2,5]thiadiazole)] (PCPDTBT) with ethylhexyl
side-chains. Upon doping with a Lewis acid, B(C6F5)3, the maximum electrical conductivity (7.47 S cm–1) of PCPDTSBT is ∼1 order higher than that
(0.65 S cm–1) of PCPDTBT, and the best power factor
is measured to be 7.73 μW m–1 K–2 for PCPDTSBT with doping 9 mol % of B(C6F5)3. The Seebeck coefficient–electrical conductivity
relation is analyzed by using a charge transport model for polymers,
suggesting that the doped PCPDTSBT film has superb charge transport
property based on a high crystallinity with olefinic side-chains.
This study emphasizes the importance of side-chain engineering by
using the sp2-hybridized olefinic substituents to modulate
interchain packing, crystalline morphology, and the resulting electrical
properties.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.